Sanofi plans to revamp U.S. research operations as well as further reduce sales positions. "Both initiatives are part of Sanofi's three-pronged strategy of increasing innovation in research and development, pursuing external growth opportunities and adapting the organization for future challenges and opportunity," the company said.

Full Story:

Related Summaries